Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Akero Therapeutics (NASDAQ: AKRO)
Follow
NASDAQ:AKRO
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
AKRO
Akero Therapeutics
Young Jonathan
/
officer: Chief Operating Officer
01/02/2025
Sell
$28.03
10,000
$280K
218,083
NASDAQ
AKRO
Akero Therapeutics
Young Jonathan
/
officer: Chief Operating Officer
12/16/2024
Buy
$29.23
73,700
$2.154M
73,700
NASDAQ
AKRO
Akero Therapeutics
Lamy Patrick
/
officer: Senior VP, Commercial Strategy
12/16/2024
Buy
$29.23
52,100
$1.523M
52,100
NASDAQ
AKRO
Akero Therapeutics
Lamy Patrick
/
officer: Senior VP, Commercial Strategy
12/16/2024
Sell
$29.13
1,000
$29K
34,258
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
12/16/2024
Buy
$21.10
9,074
$191K
104,722
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
12/16/2024
Sell
$29.11
9,074
$264K
95,648
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
12/16/2024
Buy
$29.23
73,700
$2.154M
73,700
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
12/16/2024
Sell
$21.10
9,074
$191K
20,000
NASDAQ
AKRO
Akero Therapeutics
White William Richard
/
officer: Chief Financial Officer
12/16/2024
Buy
$29.23
73,700
$2.154M
73,700
NASDAQ
AKRO
Akero Therapeutics
Gangloff Scott A.
/
officer: Chief Technology Officer
12/16/2024
Buy
$29.23
73,700
$2.154M
73,700
NASDAQ
AKRO
Akero Therapeutics
Rolph Timothy
/
officer: Chief Scientific Officer
12/17/2024
Buy
$19.87
3,800
$76K
182,137
NASDAQ
AKRO
Akero Therapeutics
Rolph Timothy
/
officer: Chief Scientific Officer
12/17/2024
Sell
$31.10
3,800
$118K
178,337
NASDAQ
AKRO
Akero Therapeutics
Rolph Timothy
/
officer: Chief Scientific Officer
12/17/2024
Sell
$19.87
3,800
$76K
134,955
NASDAQ
AKRO
Akero Therapeutics
Rolph Timothy
/
officer: Chief Scientific Officer
12/16/2024
Buy
$29.23
60,000
$1.754M
60,000
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
12/16/2024
Buy
$29.23
295,600
$8.640M
295,600
NASDAQ
AKRO
Akero Therapeutics
Rolph Timothy
/
officer: Chief Scientific Officer
12/10/2024
Buy
$19.87
2,450
$49K
180,787
NASDAQ
AKRO
Akero Therapeutics
Rolph Timothy
/
officer: Chief Scientific Officer
12/10/2024
Sell
$31.03
2,450
$76K
178,337
NASDAQ
AKRO
Akero Therapeutics
Rolph Timothy
/
officer: Chief Scientific Officer
12/10/2024
Sell
$30.79
2,368
$73K
178,337
NASDAQ
AKRO
Akero Therapeutics
Rolph Timothy
/
officer: Chief Scientific Officer
12/10/2024
Sell
$19.87
2,450
$49K
138,755
NASDAQ
AKRO
Akero Therapeutics
Young Jonathan
/
officer: Chief Operating Officer
12/10/2024
Sell
$30.79
2,503
$77K
203,783
NASDAQ
AKRO
Akero Therapeutics
Lamy Patrick
/
officer: Senior VP, Commercial Strategy
12/10/2024
Sell
$30.79
925
$28K
17,858
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
12/10/2024
Sell
$30.79
2,810
$87K
71,348
NASDAQ
AKRO
Akero Therapeutics
White William Richard
/
officer: Chief Financial Officer
12/10/2024
Sell
$30.79
2,817
$87K
38,335
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
12/10/2024
Sell
$30.79
7,855
$242K
597,562
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
12/02/2024
Buy
$21.10
25,000
$528K
630,417
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
12/02/2024
Sell
$32.09
25,000
$802K
605,417
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
12/02/2024
Sell
$21.10
25,000
$528K
111,029
NASDAQ
AKRO
Akero Therapeutics
Young Jonathan
/
officer: Chief Operating Officer
12/02/2024
Sell
$32.13
10,000
$321K
206,286
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
11/15/2024
Buy
$21.10
9,061
$191K
83,219
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
11/15/2024
Sell
$27.69
8,761
$243K
74,458
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
11/15/2024
Sell
$28.82
300
$9K
74,158
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
11/15/2024
Sell
$21.10
9,061
$191K
53,421
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.